Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM - Wikidata - wikimedia - TriplyDB

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

http://www.wikidata.org/entity/Q34992526

about

Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)Imaging tumor metabolism using in vivo magnetic resonance spectroscopy The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels Magnetic Resonance (MR) Metabolic Imaging in Glioma.Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Choline metabolism in malignant transformation.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.[Application of ultrahigh-field MRI in neuro-oncology].

P2860

Q26751944-EAE5D07D-C8FA-4EF5-A068-E0901F45FD0B Q27002499-E8358DD1-67FB-4B91-9BC7-5F3D4E9B4F8B Q30797166-F63E2EBE-DACA-48D5-86CF-059D064096C7 Q30831591-A19A99EF-F9AB-4E58-8CE0-2AA393178521 Q31015256-B6C74567-D7E2-4DAE-BA08-086C226278B6 Q31144824-DE629A05-1CA6-465B-B674-62EB24BF5747 Q33888366-2042A225-7231-4219-BB36-CFBCB24230F3 Q35112040-73CFDA38-FDD7-40D2-A037-E46AD4CAB64E Q35738941-DF02DB8D-9D37-4A9F-AB26-DD111AF54F2A Q36235508-C04F8AC2-712B-4E16-93A4-185EFDC87579 Q37168287-B47F38D8-C04C-4588-B3D4-DB9A6FF3743B Q37697784-C97A3A01-ACB2-40D3-9EA1-2D59854F6C0E Q39042132-29D8C9E2-D6CE-4CE5-AA58-5D1B99B88DAD Q40118689-CE016BF5-BADF-4DFB-A329-B10037E5FDB4 Q42363638-A1132528-DBF9-4F9D-BC53-763F3900E1BF Q44844537-C75596B1-CA6D-46A4-919F-8B92E61D25B6 Q46623342-63CA3628-4B1C-4428-B3D3-167D37E29947 Q46664688-E5B3B1C7-511A-4609-85EA-BCC83B5B0937 Q48314259-780FDF9E-2263-4537-A9C4-40DF2EC0751D Q48519374-ED8ADC19-60CD-49D4-A33C-7F0D1B0B3A8A Q53111871-EC726851-ACEF-4F5A-8B9D-1AE83DE1B027

P2860

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

http://www.wikidata.org/entity/Q34992526

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@ast

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@en

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@nl

type

label

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@ast

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@en

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@nl

prefLabel

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@ast

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@en

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@nl

P1433

Q34992526-4FDC2180-680A-440C-A016-4C2ED3C2CDA0

P1476

Q34992526-F0EA68DA-916D-4FBF-800A-4EFFFD7EB98C

P2093

Q34992526-796870D1-6B3E-4E45-9724-BAC2F29A9D31

Q34992526-841C0D20-DFEB-4039-AD5F-1C0877A918B6

Q34992526-942B23DF-957A-433A-A668-41464535B3EF

Q34992526-BA81A997-0E2B-4CDA-8130-A87F1A276A28

Q34992526-C03E139B-933C-4F87-9FEF-D95542B16F5A

Q34992526-C8FCC82B-E51E-49F8-ABA7-0AD62F44E746

Q34992526-CE975990-4B12-4BD0-A48A-8A13CDE1B265

Q34992526-D4C239CA-9571-4FE7-A6C8-DB265B18FF66

Q34992526-DFAD4082-693E-4E87-954B-CA69DB5F26F5

Q34992526-EBC7E690-3208-4FB8-8841-744EDA59A01C

P2860

Q34992526-0D68064C-41FE-4DDC-A4EC-D4335A80081D

Q34992526-10304B08-1BE1-48C4-A066-368E4C326C05

Q34992526-21D0EF40-8D68-4B87-A0B3-A9CC882AB1CC

Q34992526-2815F9BA-11B5-444E-AFDB-A853326A4B48

Q34992526-28224003-0571-4CD3-85BD-0C0D76716ECA

Q34992526-309E429C-E010-4736-AD17-EEB1D0D946DE

Q34992526-3B3A8325-9881-4D40-838B-16EECBAEED51

Q34992526-44D911C7-C3FC-4EC4-BB82-E150604DEE48

Q34992526-54E4995E-EEBC-4BDB-AFC9-978DD8698D6E

Q34992526-56F801E9-3FCB-43B0-8263-6325C621FB44

P304

Q34992526-B4C57D68-02B9-4A01-98FD-EDD7E02938B4

P31

Q34992526-D8A971A4-93CD-4BD3-B2F9-9B67C18E8DCE

P356

Q34992526-8957875A-2F5A-4B8B-B94F-8E5B8EC19D54

P433

Q34992526-F476F811-BFCB-4136-9210-6E5E2956964F

P478

Q34992526-D75FE88A-8A52-470D-8241-67BF807C589A

P577

Q34992526-2AF893EB-E876-42F1-A367-D82E3EAC9D11

P5875

Q34992526-8DB4A128-31B2-480F-ACF6-A20E9153FA6D

P698

Q34992526-FA3D4ABB-A75F-4D9D-999A-803B919D4BB7

P932

Q34992526-FA8CB0F9-6C2A-489E-8C6E-DCF971BFCD9E

P356

P1433

P1476

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM

@en

P2093

Alvin Au

http://www.w3.org/2001/XMLSchema#string

Andrea Pirzkall

http://www.w3.org/2001/XMLSchema#string

Gabriela Bourne

http://www.w3.org/2001/XMLSchema#string

Joanna J Phillips

http://www.w3.org/2001/XMLSchema#string

Mei-Yin C Polley

http://www.w3.org/2001/XMLSchema#string

Radhika Srinivasan

http://www.w3.org/2001/XMLSchema#string

Sarah J Nelson

http://www.w3.org/2001/XMLSchema#string

Scott R Vandenberg

http://www.w3.org/2001/XMLSchema#string

Soonmee Cha

http://www.w3.org/2001/XMLSchema#string

Susan M Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

Choline kinase: a novel target for antitumor drugs

Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors.

MRI in treatment of adult gliomas.

Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T.

Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

P304

1152-1161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ075

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45278359

http://www.w3.org/2001/XMLSchema#string

P698

20647244

http://www.w3.org/2001/XMLSchema#string

P932

3098023

http://www.w3.org/2001/XMLSchema#string